Literature DB >> 15996055

High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis.

Miguel A Gonzalez-Gay1, Carlos Gonzalez-Juanatey, Angela Piñeiro, Carlos Garcia-Porrua, Ana Testa, Javier Llorca.   

Abstract

OBJECTIVE: Patients with rheumatoid arthritis (RA) are at greater risk of developing cardiovascular events compared with individuals without RA. Increased risk for cardiovascular disease in these patients is a consequence of atherosclerosis. Case-control studies have shown that increased intima-media thickness (IMT) of the common carotid artery is an indicator of generalized atherosclerosis. Some investigators have suggested that the development of atherosclerosis in RA may be related to the magnitude and chronicity of the systemic inflammation. We examined the relationship between carotid IMT to C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which are the most commonly assessed markers of inflammatory response in patients with RA.
METHODS: Retrospective review of CRP and ESR values in 47 patients with longterm actively treated (at least 5 years) RA without clinically evident atherosclerosis or its complications, who had been studied for carotid IMT with high resolution B-mode ultrasound.
RESULTS: No correlation between ESR and carotid IMT was observed. However, a correlation was found between the maximum CRP values and the carotid IMT (p = 0.009). The distribution of patients in 4 quartiles according to the average CRP values showed significant differences in the carotid IMT (p = 0.03). Those exhibiting the highest mean CRP values (quartile 4) had greater carotid IMT. There was no correlation between CRP at the time of disease diagnosis or at the time of the ultrasound study and the carotid IMT.
CONCLUSION: Our study confirms that the magnitude and chronicity of the inflammatory response measured by CRP correlates directly with the presence of atherosclerosis in patients with RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15996055

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  70 in total

1.  N-terminal prohormone brain natriuretic peptide: a biomarker for detecting cardiovascular risks in patients with rheumatoid arthritis or osteoarthritis?

Authors:  Thomas Häupl; Gerd R Burmester; Evangelos Giannitsis; Thorsten Rohrlach; Eberhard Spanuth; Hans Parsch; Kay Brune
Journal:  Ann Rheum Dis       Date:  2007-06       Impact factor: 19.103

2.  Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap.

Authors:  Diane Lacaille; J Antonio Avina-Zubieta; Eric C Sayre; Michal Abrahamowicz
Journal:  Ann Rheum Dis       Date:  2016-12-28       Impact factor: 19.103

3.  Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis.

Authors:  Sara S McCoy; Cynthia S Crowson; Hilal Maradit-Kremers; Terry M Therneau; Veronique L Roger; Eric L Matteson; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2013-02-15       Impact factor: 4.666

4.  Rheumatoid arthritis and atypical cardiovascular disease: inflammation changing the clinical presentation.

Authors:  Marco Iafolla
Journal:  Can Fam Physician       Date:  2013-05       Impact factor: 3.275

5.  Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index.

Authors:  Carmen Gómez-Vaquero; Montserrat Robustillo; Javier Narváez; Jesús Rodríguez-Moreno; Carlos González-Juanatey; Javier Llorca; Joan Miquel Nolla; Miguel Angel González-Gay
Journal:  Clin Rheumatol       Date:  2011-05-13       Impact factor: 2.980

Review 6.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

7.  Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation.

Authors:  Jawl-Shan Hwang; Tsu-Lan Wu; S C Chou; C Ho; Pi-Yueh Chang; Kuo-Chien Tsao; Jeng-Yi Huang; Chien-Feng Sun; James T Wu
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

8.  Vascular function and inflammation in rheumatoid arthritis: the role of physical activity.

Authors:  George S Metsios; Antonios Stavropoulos-Kalinoglou; Aamer Sandoo; Jet J C S Veldhuijzen van Zanten; Tracey E Toms; Holly John; George D Kitas
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 9.  Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.

Authors:  Santos Castañeda; Carlos González-Juanatey; Miguel A González-Gay
Journal:  Clin Rev Allergy Immunol       Date:  2019-06       Impact factor: 8.667

10.  Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.

Authors:  Jonathan Graf; Rebecca Scherzer; Carl Grunfeld; John Imboden
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.